Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Kava for the treatment of generalized anxiety disorder RCT: analysis of adverse reactions, liver function, addiction, and sexual effects.

Sarris J, Stough C, Teschke R, Wahid ZT, Bousman CA, Murray G, Savage KM, Mouatt P, Ng C, Schweitzer I.

Phytother Res. 2013 Nov;27(11):1723-8. doi: 10.1002/ptr.4916. Epub 2013 Jan 24.

PMID:
23348842
2.

Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study.

Sarris J, Stough C, Bousman CA, Wahid ZT, Murray G, Teschke R, Savage KM, Dowell A, Ng C, Schweitzer I.

J Clin Psychopharmacol. 2013 Oct;33(5):643-8. doi: 10.1097/JCP.0b013e318291be67.

PMID:
23635869
3.

Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?

Sarris J, Teschke R, Stough C, Scholey A, Schweitzer I.

Planta Med. 2011 Jan;77(2):107-10. doi: 10.1055/s-0030-1250290. Epub 2010 Sep 2.

PMID:
20814850
4.

The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum.

Sarris J, Kavanagh DJ, Byrne G, Bone KM, Adams J, Deed G.

Psychopharmacology (Berl). 2009 Aug;205(3):399-407. doi: 10.1007/s00213-009-1549-9. Epub 2009 May 9.

PMID:
19430766
5.

The acute effects of kava and oxazepam on anxiety, mood, neurocognition; and genetic correlates: a randomized, placebo-controlled, double-blind study.

Sarris J, Scholey A, Schweitzer I, Bousman C, Laporte E, Ng C, Murray G, Stough C.

Hum Psychopharmacol. 2012 May;27(3):262-9. doi: 10.1002/hup.2216. Epub 2012 Feb 7.

PMID:
22311378
6.

Therapeutic potential of kava in the treatment of anxiety disorders.

Singh YN, Singh NN.

CNS Drugs. 2002;16(11):731-43. Review.

PMID:
12383029
7.

Kava Anxiety Depression Spectrum Study (KADSS): a mixed methods RCT using an aqueous extract of Piper methysticum.

Sarris J, Kavanagh DJ, Adams J, Bone K, Byrne G.

Complement Ther Med. 2009 Jun;17(3):176-8. doi: 10.1016/j.ctim.2009.01.001. Epub 2009 Feb 7.

PMID:
19398072
8.

Kava in generalized anxiety disorder: three placebo-controlled trials.

Connor KM, Payne V, Davidson JR.

Int Clin Psychopharmacol. 2006 Sep;21(5):249-53.

PMID:
16877894
10.
11.
12.

A placebo-controlled study of Kava kava in generalized anxiety disorder.

Connor KM, Davidson JR.

Int Clin Psychopharmacol. 2002 Jul;17(4):185-8.

PMID:
12131602
13.

Kava: a comprehensive review of efficacy, safety, and psychopharmacology.

Sarris J, LaPorte E, Schweitzer I.

Aust N Z J Psychiatry. 2011 Jan;45(1):27-35. doi: 10.3109/00048674.2010.522554. Epub 2010 Nov 15. Review.

PMID:
21073405
14.

Anxiolytic effects of kava extract and kavalactones in the chick social separation-stress paradigm.

Smith KK, Dharmaratne HR, Feltenstein MW, Broom SL, Roach JT, Nanayakkara NP, Khan IA, Sufka KJ.

Psychopharmacology (Berl). 2001 Apr;155(1):86-90.

PMID:
11374340
15.

Kava treatment in patients with anxiety.

Geier FP, Konstantinowicz T.

Phytother Res. 2004 Apr;18(4):297-300.

PMID:
15162364
16.

Does a medicinal dose of kava impair driving? A randomized, placebo-controlled, double-blind study.

Sarris J, Laporte E, Scholey A, King R, Pipingas A, Schweitzer I, Stough C.

Traffic Inj Prev. 2013;14(1):13-7. doi: 10.1080/15389588.2012.682233.

PMID:
23259514
17.

Efficacy of kava extract for treating anxiety: systematic review and meta-analysis.

Pittler MH, Ernst E.

J Clin Psychopharmacol. 2000 Feb;20(1):84-9.

PMID:
10653213
18.

Therapeutic effectiveness of Galphimia glauca vs. lorazepam in generalized anxiety disorder. A controlled 15-week clinical trial.

Herrera-Arellano A, Jiménez-Ferrer JE, Zamilpa A, García-Alonso G, Herrera-Alvarez S, Tortoriello J.

Planta Med. 2012 Sep;78(14):1529-35. Epub 2012 Jul 24.

PMID:
22828921
19.

Anxiolytic properties of Piper methysticum extract samples and fractions in the chick social-separation-stress procedure.

Feltenstein MW, Lambdin LC, Ganzera M, Ranjith H, Dharmaratne W, Nanayakkara NP, Khan IA, Sufka KJ.

Phytother Res. 2003 Mar;17(3):210-6.

PMID:
12672148
20.

Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines.

Malsch U, Kieser M.

Psychopharmacology (Berl). 2001 Sep;157(3):277-83.

PMID:
11605083
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk